Huntington Man Pleads Guilty in Federal Court

HUNTINGTON, W.Va. – Jacob Hatfield, 26, of Huntington, pleaded guilty yesterday in federal court before United States District Judge Robert C. Chambers to aiding and abetting the distribution of a quantity of oxymorphone, also known as “Opana.”  Hatfield admitted that on November 18, 2011, he sold 25 Opana pills to a known individual in exchange for $1250. 

The defendant further admitted that he was aware that the known individual intended to further distribute the pills to a third individual, who was actually a confidential informant with the Metropolitan Drug Enforcement Network Team (MDENT).  Following the illicit drug transaction, the defendant was approached by officers. 

Hatfield provided consent for law enforcement to search his person and vehicle. Officers located a backpack inside the defendant’s vehicle which contained 1185 40-milligram oxymorphone pills, 865 30-milligram oxycodone pills, and 12 and 1/2 80-milligram oxycodone pills. In addition, officers found 15 40-milligram oxymorphone pills, 30 30-milligram oxycodone pills, and two suboxone pills on defendant's person. In addition to the pills, officers found $33,165 on Hatfield's person and inside of his backpack.

Hatfield faces up to 20 years in prison and a $1 million fine when he is sentenced on July 16, 2012. 

This case was prosecuted as part of an ongoing effort led by the United States Attorney’s Office for the Southern District of West Virginia to combat the illicit sale and misuse of prescription drugs.  The U.S. Attorney’s Office, joined by various federal, state and local law enforcement agencies, remain committed to aggressively pursuing and shutting down illegal pill trafficking, eliminating open air drug markets and curtailing the spread of opiate painkillers in communities across the Southern District. 

The Metropolitan Drug Enforcement Network Team (MDENT) conducted the investigation.  Assistant United States Attorney Monica Dillon is in charge of the prosecution.
Comments powered by Disqus